ログアウト
donwloadimg

アプリをダウンロード

ログイン後利用可能
トップに戻る

NEWS

CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance With Minimum Bid Price Requirement
HOUSTON, TX / ACCESSWIRE / November 1, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that on October 30, 2024, it received notice from The Nasdaq Hearings Panel that the Company has been granted an exception until March 11, 2025, to regain compliance with the minimum bid price requirement in Listing Rule 5550(a)(2).
免責事項:このコミュニティは、Moomoo Technologies Inc.が教育目的でのみ提供するものです。 さらに詳しい情報
1
1
+0
2
翻訳
報告
6513 回閲覧
コメント
サインインコメントをする